Back to search
Advanced Chronic Liver Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Chronic Liver Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Chronic Liver Disease trials you may qualify forThe goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advan…
How to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general…
The aim of this observational study is to predict the short- and long-term development of acute severe disease events, de novo hepatocarcinoma (HCC) and mortali…
The primary objective of this study is to evaluate the role of spleen shear wave elastography (SWE-SSM) for ruling in and ruling out clinically significant port…
This study looks to gather data on hepatomiR, a CE-certified test already intended for gauging liver-related outcomes, in order to define a cut-off regarding sp…
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
This multicenter, prospective, cohort study is designed to investigate how metabolic disorders (such as obesity, diabetes, and high cholesterol) influence the p…
This is a single-arm clinical trial. The main objective is to determine the efficacy of atezolizumab+bevacizumab therapy in patients with advanced hepatocellula…
Biotherapies are biological (extracted from an organism or living tissue) or biotechnological drugs used in the treatment of multiple conditions, such as autoim…